You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Recombinant Vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial (SARS-CoV-2 Subunit Recombinant Protein Vaccine)

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Subunit Recombinant Protein Vaccine
  • (no location specified)
Jul 5, 2023

COVID-19 Trial in Bandung (SARS-CoV-2 subunit protein recombinant vaccine)

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 subunit protein recombinant vaccine
  • Bandung, Jawa Barat, Indonesia
    Faculty of Medicine Universitas Padjadjaran
Feb 13, 2023

Cervical Cancer, Genital Wart, CIN1 Trial (Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine

Not yet recruiting
  • Cervical Cancer
  • +11 more
  • Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine (Hansenula Polymorpha)
  • Placebo
  • (no location specified)
Oct 17, 2022

Covid19 Trial in Jakarta (SARS-CoV-2 Protein Subunit Recombinant Vaccine, SARS-CoV-2 Inactivated Vaccine)

Completed
  • Covid19
  • SARS-CoV-2 Protein Subunit Recombinant Vaccine
  • SARS-CoV-2 Inactivated Vaccine
  • Jakarta, Greater Jakarta, Indonesia
    Fakultas Kedokteran Universitas Indonesia
Aug 8, 2022

Idiopathic CD4 T Cell Lymphocytopenia Trial run by the NIAID (Gardasil 9)

Recruiting
  • Idiopathic CD4 T Cell Lymphocytopenia
  • Gardasil 9
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 10, 2023

COVID-19 Trial in Semarang, Jakarta (SARS-CoV-2 protein subunit recombinant vaccine, SARS-CoV-2 inactivated vaccine)

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 protein subunit recombinant vaccine
  • SARS-CoV-2 inactivated vaccine
  • Semarang, Central Java, Indonesia
  • +1 more
Aug 8, 2022

Vaccine Reaction, Vaccine Adverse Reaction Trial (SARS-CoV-2 Protein Subunit Recombinant Vaccine, Active Comparator)

Recruiting
  • Vaccine Reaction
  • Vaccine Adverse Reaction
  • SARS-CoV-2 Protein Subunit Recombinant Vaccine
  • Active Comparator
  • Denpasar, Bali, Indonesia
  • +9 more
Dec 12, 2022

Cervical Cancer, Genital Wart, CIN Trial in Nanning (Zerun HPV-9, GARDASIL ®9)

Active, not recruiting
  • Cervical Cancer
  • +4 more
  • Zerun HPV-9
  • GARDASIL ®9
  • Nanning, Guangxi, China
    GuangXi Center for Diseases Control and Prevention
Oct 26, 2022

COVID-19 Trial in Indonesia (COVID-19 Protein Subunit Recombinant Vaccine, Active Comparator)

Recruiting
  • COVID-19
  • COVID-19 Protein Subunit Recombinant Vaccine
  • Active Comparator
  • Semarang, Central Java, Indonesia
  • +3 more
Jun 26, 2022

COVID-19 Trial in Semarang, Makassar, Padang (SARS-CoV-2 protein subunit recombinant vaccine, )

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 protein subunit recombinant vaccine
  • placebo
  • Semarang, Central Java, Indonesia
  • +2 more
Aug 8, 2022

Rheumatoid Arthritis, Spondylitis, Ankylosing, Spondyloarthritis Trial in São Paulo (Recombinant Herpes Zoster Vaccine (RZV),

Recruiting
  • Rheumatoid Arthritis
  • +9 more
  • Recombinant Herpes Zoster Vaccine (RZV)
  • +5 more
  • São Paulo, Sao Paulo, Brazil
    Rheumatology Division of Hospital das Clínicas da Faculdade de M
May 24, 2023

Coronavirus Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant novel

Not yet recruiting
  • Coronavirus
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Recombinant novel coronavirus protein vaccine (CHO cells)
  • (no location specified)
Sep 5, 2023

Vaccine-Preventable Diseases, Herpes Zoster Trial in Zhenjiang (Recombinant Herpes Zoster Vaccine, Recombinant Herpes Zoster

Recruiting
  • Vaccine-Preventable Diseases
  • Herpes Zoster
  • Recombinant Herpes Zoster Vaccine
  • Recombinant Herpes Zoster Vaccine Placebo
  • Zhenjiang, Jiangsu, China
    Jiangsu Province Center for Disease Control and Prevention (Chin
Oct 12, 2023

Childhood Cancer, Multiple Diseases Trial in New York (Immunization Schedule patients <7 years., Immunization Schedule patients

Active, not recruiting
  • Childhood Cancer
  • Multiple Diseases
  • Immunization Schedule patients <7 years.
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center 1275 York Avenue
Aug 9, 2022

COVID-19 Trial (Recombinant variant COVID-19 vaccine (Sf9 cell), Recombinant COVID-19 vaccine (CHO cell), Recombinant COVID-19

Not yet recruiting
  • COVID-19
  • Recombinant variant COVID-19 vaccine (Sf9 cell)
  • +2 more
  • (no location specified)
Mar 10, 2023

Schistosomiasis Mansoni, Schistosomiasis Haematobium, Vaccination; Infection Trial in Saint Louis (Sm14 recombinant vaccine+

Recruiting
  • Schistosomiasis Mansoni
  • +2 more
  • Sm14 recombinant vaccine+ GLA-SE adjuvant
  • Saint Louis, Senegal
    Biomedical Research Center EPLS
Dec 13, 2022

Coronavirus Trial in Wuhu (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant

Active, not recruiting
  • Coronavirus
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Recombinant novel coronavirus protein vaccine (CHO cells)
  • Wuhu, Anhui, China
    Wannan Medical College Yijishan Hospital
May 6, 2023

COVID-19 Trial (Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C), Recombinant COVID-19

Not yet recruiting
  • COVID-19
  • Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C)
  • Recombinant COVID-19 vaccine(Sf9 Cell) (WSK-V101)
  • (no location specified)
Jun 19, 2023

Vaccination; Infection, Vaccine Adverse Reaction Trial (Recombinant zoster vaccination)

Not yet recruiting
  • Vaccination; Infection
  • Vaccine Adverse Reaction
  • Recombinant zoster vaccination
  • (no location specified)
Jun 9, 2023

COVID-19 Trial in Changsha (Recombinant Novel Coronavirus vaccine (CHO Cells))

Completed
  • COVID-19
  • Recombinant Novel Coronavirus vaccine (CHO Cells)
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Jun 6, 2023

COVID-19 Trial (High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell), Low dose of Recombinant

Not yet recruiting
  • COVID-19
  • High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell)
  • +3 more
  • (no location specified)
Jun 19, 2023

Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Yangchun (4-valent HPV Vaccine, 9-valent HPV Vaccine, GARDASIL®)

Completed
  • Cervical Cancer
  • +13 more
  • 4-valent HPV Vaccine
  • +2 more
  • Yangchun, Guangdong, China
    Yangchun Center For Disease Prevention And Control
Feb 23, 2022

Gastroenteritis Trial (Recombinant Norovirus Hexavalent Vaccine, Matching Placebo)

Not yet recruiting
  • Gastroenteritis
  • Recombinant Norovirus Hexavalent Vaccine
  • Matching Placebo
  • (no location specified)
Mar 27, 2023

Herpes Zoster Trial in Makati City (REC610, Shingrix)

Recruiting
  • Herpes Zoster
  • REC610
  • Shingrix
  • Makati City, Metro Manila, Philippines
    Pharma Peak Research Philippines,Inc.
Mar 13, 2023

Herpes Zoster, Vaccine-Preventable Diseases Trial (Low Dose Recombinant Herpes Zoster Vaccine (LZ901), High Dose Recombinant

Not yet recruiting
  • Herpes Zoster
  • Vaccine-Preventable Diseases
  • Low Dose Recombinant Herpes Zoster Vaccine (LZ901)
  • +2 more
  • (no location specified)
Feb 28, 2023